Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know
This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.
Overview
Stephen M. Mason, CEO of the firm's GMPD Segment, sold 35,000 shares of Cardinal Health, Inc. (NYSE:CAH) on August 18, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($236.40); post-transaction value based on the August 18 market close ($234.98).
Details
Cardinal Health is one of the largest healthcare services and products companies globally, with a TTM revenue base of $254.2 billion and a market capitalization of $55.0 billion. The company maintains a competitive advantage through its integrated distribution network, scale across pharmaceutical and medical segments, and established relationships with a broad spectrum of healthcare providers across multiple geographies. Cardinal Health is positioned as a critical infrastructure provider within the healthcare supply chain, supporting the delivery of care across institutional and individual patient settings.
Source
Originally published at www.fool.com.